As suggested by Mohammadhosayni et al. [86], the high levels of inflammatory cytokines, such as TNF-α, might help to increase the production of MMPs, leading to BBB disruption in COVID-19 patients with neurological symptoms. The gene discussed is TNF; the disease is COVID-19.